These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 18243696)
1. A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy. Yoneda Y; Steiniger SC; Capková K; Mee JM; Liu Y; Kaufmann GF; Janda KD Bioorg Med Chem Lett; 2008 Mar; 18(5):1632-6. PubMed ID: 18243696 [TBL] [Abstract][Full Text] [Related]
2. Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. Kim Y; Lillo AM; Steiniger SC; Liu Y; Ballatore C; Anichini A; Mortarini R; Kaufmann GF; Zhou B; Felding-Habermann B; Janda KD Biochemistry; 2006 Aug; 45(31):9434-44. PubMed ID: 16878978 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery. Liu Y; Steiniger SC; Kim Y; Kaufmann GF; Felding-Habermann B; Janda KD Mol Pharm; 2007; 4(3):435-47. PubMed ID: 17373820 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
5. Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy. Qiao Y; Dsouza C; Matthews AA; Jin Y; He W; Bao J; Jiang F; Chandna R; Ge R; Fu L Eur J Med Chem; 2020 May; 193():112228. PubMed ID: 32199134 [TBL] [Abstract][Full Text] [Related]
6. Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents. Loktev A; Haberkorn U; Mier W Curr Med Chem; 2017; 24(20):2141-2155. PubMed ID: 28302013 [TBL] [Abstract][Full Text] [Related]
7. Absolute structure of prunustatin A, a novel GRP78 molecular chaperone down-regulator. Umeda Y; Furihata K; Sakuda S; Nagasawa H; Ishigami K; Watanabe H; Izumikawa M; Takagi M; Doi T; Nakao Y; Shin-ya K Org Lett; 2007 Oct; 9(21):4239-42. PubMed ID: 17887691 [TBL] [Abstract][Full Text] [Related]
8. Interaction of murine BiP/GRP78 with the DnaJ homologue MTJ1. Chevalier M; Rhee H; Elguindi EC; Blond SY J Biol Chem; 2000 Jun; 275(26):19620-7. PubMed ID: 10777498 [TBL] [Abstract][Full Text] [Related]
9. Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78. Nayak D; Katoch A; Sharma D; Faheem MM; Chakraborty S; Sahu PK; Chikan NA; Amin H; Gupta AP; Gandhi SG; Mukherjee D; Goswami A Breast Cancer Res Treat; 2019 Sep; 177(2):307-323. PubMed ID: 31175498 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues. Chiba T; Kitahata S; Matsuda A; Ichikawa S Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636 [TBL] [Abstract][Full Text] [Related]
11. Cyclic peptides bearing a side-chain tail: a tool to model the structure and reactivity of protein zinc sites. Sénèque O; Bourlès E; Lebrun V; Bonnet E; Dumy P; Latour JM Angew Chem Int Ed Engl; 2008; 47(36):6888-91. PubMed ID: 18651686 [No Abstract] [Full Text] [Related]
12. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16. Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery. Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship study of syringolin A as a potential anticancer agent. Chiba T; Matsuda A; Ichikawa S Bioorg Med Chem Lett; 2015 Nov; 25(21):4872-4877. PubMed ID: 26231162 [TBL] [Abstract][Full Text] [Related]
15. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth. Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Activity of Isosyringolin A. Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978 [TBL] [Abstract][Full Text] [Related]
17. [Isolation and identification of antineoplastic cyclic peptide]. Liang Q; Liao XJ; Xu SH; Xu WJ Zhong Yao Cai; 2010 Feb; 33(2):213-5. PubMed ID: 20575412 [TBL] [Abstract][Full Text] [Related]
18. GRP78-targeted in-silico virtual screening of novel anticancer agents. Viswanath ANI; Lim JW; Seo SH; Lee JY; Lim SM; Pae AN Chem Biol Drug Des; 2018 Aug; 92(2):1555-1566. PubMed ID: 29718569 [TBL] [Abstract][Full Text] [Related]
19. Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70. Wang Y; McAlpine SR Org Biomol Chem; 2015 Feb; 13(7):2108-16. PubMed ID: 25526223 [TBL] [Abstract][Full Text] [Related]
20. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Arap MA; Lahdenranta J; Mintz PJ; Hajitou A; Sarkis AS; Arap W; Pasqualini R Cancer Cell; 2004 Sep; 6(3):275-84. PubMed ID: 15380518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]